• Publications
  • Influence
Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression
There is a significant need for reliable molecular biomarkers to aid in Alzheimer's disease (AD) clinical diagnosis.
  • 69
  • 1
Circadian pharmacology of l-alanosine (SDX-102) in mice
l-Alanosine (SDX-102) exerts its cytotoxicity through inhibition of de novo purine biosynthesis, an effect potentiated by methylthioadenosine phosphorylase (MTAP) deficiency. The relevance ofExpand
  • 11
  • PDF
Amphotericin B susceptibility testing of Candida lusitaniae isolates by flow cytofluorometry: comparison with the Etest and the NCCLS broth macrodilution method.
A flow cytofluorometric susceptibility test (FCST) was used for rapid determination of the susceptibility of Candida lusitaniae isolates to amphotericin B. The test is based on the decrease inExpand
  • 21
Blood transcriptomic biomarkers of Alzheimer's disease patients treated with EHT 0202.
Monitoring the genomic expression of patients in clinical trials for Alzheimer's disease (AD) can assist trial design and treatment response analysis. Here, we report on the identification in ADExpand
  • 7
  • PDF
Validation d’une signature transcriptomique (EHT Dx14) sur des échantillons de tumeurs mammaires prélevés par cytoponction à l’aiguille fine
La cytoponction a l’aiguille fine est une procedure simple, rapide et peu onereuse qui a montre son utilite dans le diagnostic du cancer mammaire [1]. Celle-ci est cependant associee a une frequenceExpand